862251-53-4

Upstream product

• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 862297-90-3 1,4-bis-[5-(tert-butyl-diphenyl-silanyloxy)-4-dimethylamino-6-methyl-5,6-dihydro-4H-pyran-2-yl]-4-triethylsilanyloxy-cyclohexa-2,5-dienol 
• 862251-54-5 4-[5-(tert-butyl-diphenyl-silanyloxy)-4-dimethylamino-6-methyl-5,6-dihydro-4H-pyran-2-yl]-4-hydroxy-4H-naphthalen-1-one 
• 862205-06-9 4-[5-(tert-butyl-diphenyl-silanyloxy)-4-dimethylamino-6-methyl-5,6-dihydro-4H-pyran-2-yl]-4-hydroxy-cyclohexa-2,5-dienone 

Relevant academic research and scientific papers

The "reverse polarity" approach to ravidomycin. Aryl C-aminoglycosides from a lithiated aminoglycal

A three-step sequence affects the regio- and stereospecific elaboration of an aryl C-aminoglycoside from a simple aminoglycal and a quinone. Direct lithiation of the glycal followed by addition of the quinone, reduction of the quinol adduct, and hydrobora